Web Stats Provided By Google Analytics

Thursday, October 13, 2016

Ocular Therapeutix (OCUL) Stock Soars on Regeneron Deal

Shares of Ocular Therapeutix were up 17.43% to $7.41 on heavy trading volume early-afternoon Thursday as the Bedford, MA-based company is partnering with the Tarrytown, NY-based biotechnology company Regeneron Pharmaceuticals . Under the agreement, the companies will collaborate on the development of a sustained release formulation of aflibercept, Regeneron's retinal disease treatment.

No comments:

Post a Comment

Popular Tarrytown Roundup Posts